SonoScape Medical Corp
SZSE:300633

Watchlist Manager
SonoScape Medical Corp Logo
SonoScape Medical Corp
SZSE:300633
Watchlist
Price: 34.43 CNY -5.1% Market Closed
Market Cap: 14.8B CNY
Have any thoughts about
SonoScape Medical Corp?
Write Note

SonoScape Medical Corp
Additional Paid In Capital

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

SonoScape Medical Corp
Additional Paid In Capital Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Additional Paid In Capital CAGR 3Y CAGR 5Y CAGR 10Y
SonoScape Medical Corp
SZSE:300633
Additional Paid In Capital
ÂĄ1.2B
CAGR 3-Years
60%
CAGR 5-Years
31%
CAGR 10-Years
N/A
A
APT Medical Inc
SSE:688617
Additional Paid In Capital
ÂĄ724m
CAGR 3-Years
66%
CAGR 5-Years
46%
CAGR 10-Years
N/A
J
Jiangsu Yuyue Medical Equipment & Supply Co Ltd
SZSE:002223
Additional Paid In Capital
ÂĄ2B
CAGR 3-Years
3%
CAGR 5-Years
2%
CAGR 10-Years
40%
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
Additional Paid In Capital
ÂĄ6.9B
CAGR 3-Years
-5%
CAGR 5-Years
-3%
CAGR 10-Years
N/A
J
Jafron Biomedical Co Ltd
SZSE:300529
Additional Paid In Capital
ÂĄ711.8m
CAGR 3-Years
10%
CAGR 5-Years
4%
CAGR 10-Years
N/A
Shanghai United Imaging Healthcare Co Ltd
SSE:688271
Additional Paid In Capital
ÂĄ13.9B
CAGR 3-Years
64%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

SonoScape Medical Corp
Glance View

Market Cap
14.8B CNY
Industry
Health Care

Sonoscape Medical Corp. engages in the development and sale of medical equipment. The company is headquartered in Shenzhen, Guangdong and currently employs 2,156 full-time employees. The company went IPO on 2017-04-06. The firm's main products are medical ultrasound diagnostic equipment, such as color Doppler ultrasound diagnostic equipment and B-type ultrasound diagnostic equipment, medical electronic endoscope equipment and consumables, as well as blood analyzers.

Intrinsic Value
49.61 CNY
Undervaluation 31%
Intrinsic Value
Price

See Also

What is SonoScape Medical Corp's Additional Paid In Capital?
Additional Paid In Capital
1.2B CNY

Based on the financial report for Sep 30, 2024, SonoScape Medical Corp's Additional Paid In Capital amounts to 1.2B CNY.

What is SonoScape Medical Corp's Additional Paid In Capital growth rate?
Additional Paid In Capital CAGR 5Y
31%

Over the last year, the Additional Paid In Capital growth was 6%. The average annual Additional Paid In Capital growth rates for SonoScape Medical Corp have been 60% over the past three years , 31% over the past five years .

Back to Top